Designing Biomanufacturing Networks for the Next Wave of Therapies 

In a recent byline published by BioPharm International, Anshul Mangal, CEO of Project Farma and President of PerkinElmer, shares his perspective on how biomanufacturing networks must evolve to support the next wave of advanced therapies. The article, ‘Building Robust Biomanufacturing Networks for the Next Wave of Therapies’, explores the increasing complexity of modern manufacturing ecosystems and the importance of building scalable, digitally enabled networks that can adapt as science, regulations, and market demands continue to shift. 

Click here to read Anshul’s byline for BioPharm International.